The equation used for the calculation of the phage curve assumes that 1 hr is required for the virus to be liberated after the mutation occurs and that the mutation to a virus-producing cell occurs without cell growth. This latter assumption is not necessary under these conditions but becomes necessary if very high doses of X ray are given, since in that case the cells produce virus more rapidly than they divide; i.e., C > A.
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No assumption as to cell division is necessary in the case of the other mutants, since the mutation rates of these ate very low and in this case the equations are the same, whether the mutation is assumed to appear with or without cell division.
Transformation of a sensitive cell after infection with either transforming nucleic acid23 or virus nucleic acid occurs without cell division. 23 Fox, M., J. Gen. Physiol., 42, 737 (1959) . 24 Latarjet, R., Ann. Inst. Pasteur, 81, 389 (1951). 21 Herriott, R. M., J. H. Connolly, and S. Gupta, Nature, 189, 817 (1961 Antibodies against several different haptenic groups appear to contain a tyrosine residue in their specific combining portion. Part of the evidence for a tyrosine residue is based on the loss of antibody activity when antibodies are iodinated. 1 2 That the loss is due to iodination in the specific combining portion has been shown by the fact that the antibody specific combining portion can be protected from the effects of iodination by combining the antibody with the specific hapten prior to iodination.2 Making use of this principle of specific protection, we have now been able to isolate polypeptide portions which must have come from the specific combining portion of the molecule. This was done in experiments reported here using as starting material a univalent fragment (Fraction I (Porter) 3) of the original antip-azobenzoate antibody. One portion of the fragment preparation from specifically purified antibody was iodinated with iodine labeled with J125. A second portion was combined with hapten and iodinated with iodine labeled with I'3l. The iodinations were carried out to the same extent for both portions. Subsequently, the iodinated fragments were combined and digested with pepsin to yield peptides. The peptides were separated by high-voltage electrophoresis, and it was found that the J'25-to-I31 ratio in some peptides isolated was different from that of the whole digest and this can be the case only for peptides derived from the specific combining portion of the antibody molecule.
Materials and Methods.-Specifically purified antibodies: Pooled rabbit antiserum against bovine -y-globulin coupled with diazotized p-aminobenzoic acid was used. The antiserum gave a precipitate with uncoupled bovine -y-globulin. It was treated by addition of one half the optimal amount of bovine y-globulin to remove complement, and the precipitate that was formed was removed and discarded. The -y-globulin fraction of, the remaining serum was then obtained by precipitation by sodium sulfate; two volumes of 25% sodium sulfate were added to one volume protein solution. The precipitate was separated, dissolved, and dialyzed against borate buffer.4 An optimal amount of ovalbumin coupled with diazotized p-aminobenzoate was added to form a precipitate with anti-Xp antibodies (antibodies specific to the p-azobenzoate group). The precipitate was thoroughly washed first with pH 8 borate buffer, then with 0.9% sodium chloride, and was dissolved in 0.1 M p-nitrobenzoate. This solution was placed on a diethylaminoethylcellulose (Brown Company, Berlin, N.H.) column previously equilibrated with pH 7.2, 0.02 M sodium phosphate, according to the procedure of Koshland et al.6 Elution with 0.1 M p-nitrobenzoate (adjusted to pH 7.2) resulted in the appearance of anti-X, antibody in the effluent. The antigen, X -ovalbumin, used in forming the precipitate eluted more slowly than antibody under these conditions. The eluates containing the antibody were then concentrated by precipitation with sodium sulfate and dialyzed exhaustively to remove the p-nitrobenzoate.
Papain digestion and chromatography: The antibody was digested by papain3 (Worthington Biochemicals Co., Rahway, N.J.) and checked routinely by ultracentrifugal analysis for completeness of digestion. The fragments were separated on carboxymethylcellulose (Brown Company, Berlin, N.H.) columns by the methods described by Porter.3
Radioiodine: I'25 was obtained from Dr. Paul Harper, Argonne Cancer Hospital, University of Chicago, and Ill from the Oak Ridge National Laboratory.
Iodination: Radiolabeled hypoiodite in glycine buffer pH 9 was mixed with the protein solution in borate buffer pH 9 using a simplified modification of the "jet" apparatus of McFarlane.6
The labeled hypoiodite was prepared by diluting a portion of carrier-free I'3l or I125 containing the desired amount of radioactivity (usually ca. 108 to 5 X 108 cpm) to 2 ml with 0.002 N NaOH. To this was added 0.2 ml 4 X 10-4 M ICl (in 2 N HCl), 0.5 ml 12 N HCl, and finally 0.2 ml of 4 X 10-4 M KI. The resulting 12 was extracted into 5 ml of CCl4. The CCL layer was transferred to a second tube, care being taken that no aqueous phase was included. This solution was then extracted with 3 ml of pH 9 glycine buffer (7.5 gm glycine, 16 ml of 1 N NaOH, made up to 100 ml). To 1.1 ml of this glycine solution was added 0.14 ml of 0.02 M ICl (1 M in NaCl and 0.01 N in HCl). (The buffer capacity of the glycine permits an addition of even an equal volume of ICl solution with a change in pH of only from 9.0 to 8.8). This hypoiodite solution was added to a mixture of a 1.75 ml portion of the protein solution (Fraction I, Porter) containing 10 mg protein and 0.44 ml portions of 0.5 M p-nitrobenzoate or borate buffer.4 After 50 min, the protein was dialyzed overnight at 50 against 3 1 of 1:10 borate buffer containing 8 gm NaCl per liter. The outer solution was changed, 0.1 gm KI was added to the new outer solution, and after 2 hr the outer solution was changed again; this time it was replaced with distilled water. Dialysis was continued against distilled water with hourly changes. During the 7th change, the bag contents usually became turbid; the addition of 1 ml of 88% formic acid to the outer solution cleared it within minutes. After 30 min, the solution was taken from the bag, the volume was measured, and a portion was removed for radioactivity and protein determination. The remainder was lyophilized without apparent loss and yielded a cohesive powder. Each preparation was dissolved in 0.05 M formic acid to give a concentration of 20 mg per ml (calculated on the basis of the protein taken for iodination).
Peptic digestion: 0.2 ml of each of the above -preparations in formic acid (I 12 labeled without protection and 11l labeled with protection) were mixed and 0.4 ml. of 1 M formic acid was added. To this was added 0.04 ml 0.05 M formic acid containing 0.265 mg of pepsin (2 X crystallized, Worthington). Digestion was carried out at 370 for 101/2 hr. Similar mixtures were digested for 18 and 24 hr.
Determination of radioactivity: 131 and 112 were determined in a dual-channel scintillation spectrometer using a well type scintillation head.7 Since 80% of the -rays from Ill have an energy of 0.36 Mev and 100% of the Il25 has an energy of 0.035 Mev, it is possible to count both isotopes simultaneously in a single sample by setting a separate channel to count -y rays of each of these energies. The J'5 count was corrected for the overlap of Il3l counts in the low-energy channel, which amounted to 17% of the counts in the high-level channel. All counts were corrected for a background of 20 cpm in the low channel and 100 cpm in the high chaflnel. Counts PROC. N. A. S.
were for 1-min periods and at rates of at least 5,000 cpm. All counting rates were below the limits for coincidence errors.
Determination of protein: Protein was determined by absorption at 280 mMA against buffer as a blank. For conversion of optical density units to mg per ml of protein, the factor used for fraction I was 1.50 O.D. units per mg per ml.
Results.-Part of a preparation of Fraction I (Porter) of fragments prepared from anti-azobenzoate antibodies was iodinated with iodine containing 1125 to the extent of 6.7 iodine atoms per fragment (M. W. 50,000). The same amount of the preparation was mixed with p-nitrobenzoate and iodinated similarly with IJ3l-labeled iodine to the extent of 6.1 iodine atoms per fragment. Equal volumes were then mixed, formic acid was added to 0.5 M concentration, and the mixture was digested with pepsin. The digests were frozen, lyophilized, and dissolved in 0.5 M formic acid to give 0.5 mg digest per 0.01 ml. Portions of digest were subjected to high-voltage paper electrophoresis on a GME Electrophorator (Gilson Medical Electronics Company, Middleton, Wisconsin) on Whatman No. 3MM paper (57 cm by 13 cm) with 4 per cent formic acid as electrolyte at 40 volts per cm and 3 milliamps per cm. Runs were for 320 min. The paper was dried at room temperature and cut lengthwise into 2-or 3-cm strips, and each strip was then cut into 1/4 inch sections. The amounts of I13' and I125 in each section were determined by placing the section in a plastic tube and determining the radioactivity due to each isotope with a gamma-ray spectrometer.
The results are shown in Figure 1 , where the amount of radioactivity present as each isotope is plotted against the distance on the electrophoresis paper. In this experiment, essentially all of the radioactivity applied was accounted for in the sections counted. The ratio of I125 to I13l is also shown in Figure 1 . Eleven iodinated peptide peaks were observed. Two of these showed an I'25-to-IJ3' ratio two or three times that of the whole digest. A third peak showed an IJ25-to-IJ3' ratio less than that of the whole digest. The ratios for the other peaks were approximately the same as that for the whole digest. Another pair of iodinations with and without hapten, of the antibody fragments of Fraction I, gave essentially the same results. Several digests were made of the products of both experiments. The electrophoretic analysis of each digest was made several times also with the same results. One digest was sampled after 101/2 hr and after 24 hr, and the electrophoretic patterns were the same. As a control on the iodination, some of Fraction II (Porter)3 of the same antibody was iodinated with I'3l and some with I125 (7 iodine atoms/fragment) without any protection in either case and the digestion and assay carried out as above. Although iodine-rich peaks were observed, they were in a somewhat different pattern than with iodinated Fraction I. However, there were no significant deviations in the IP25-to-Jl31 ratio from the average value, showing that any minor variations incurred during the duplicate iodination procedures are not responsible for the deviations in IJ25-to-I'3l ratios observed.
Discussion.-Those peptides having the high J125 to I'3l ratio must have been derived from a polypeptide chain associated with the specific combining portion of the antibody, since this portion would be available for iodination with 1125 but would be less available for iodination with I'3l due to the protective action of the hapten. With complete protection, the value of the ratio would be infinity.
The peak showing a low ratio of I125 to I'3l must also have been due to a polypeptide derived from the specific combining portion which contains at least two tyrosine residues not necessarily adjacent to each other, but one of which is in the specific combining portion and can be protected against iodination while the other is not. If we let AB represent this polypeptide with A representing the sequence containing the tyrosine in the combining portion and B the sequence adjacent containing the other tyrosine, then A*B, AB*, and A*B* represent the iodinated peptides with the tyrosine in A, in B, and in both A and B iodinated, respectively. With complete protection, there would be no peptides A*B or A*B* containing J131, and the ratio of I125 to J131 would be infinite. AB* on the other hand would be present in a relatively limited amount in the unprotected material at high levels of iodination, since it is an intermediate in the formation of A*B*. This gives a low value of the ratio of J125 to I'3l for AB*. Even at low iodination levels, the value for AB* would be expected to be somewhat low on probability considerations due to the fact that iodine would be distributed over at least one more iodinatable residue in the unprotected antibody than in the protected antibody. Any deviation from complete protection modifies only the magnitude of the divergence from average.
Similar reasoning applies whether tyrosine is converted to mono-iodo-or di-iodotyrosine.
